Endothelium-dependent hyperpolarizations: The history

Pharmacological Research

Volumn 49, Issue 6, 2004, Pages 503-508

  Vanhoutte, Paul M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

EDHF; Endothelium dependent hyperpolarization; Endothelium dependent relaxation; Nitric oxide; Prostacyclin

Indexed keywords

APAMIN; CALCIMYCIN; CHARYBDOTOXIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GLIBENCLAMIDE; IBERIOTOXIN; ICOSATETRAENOIC ACID; INDOMETACIN; MEPACRINE; NITRIC OXIDE; OUABAIN; POTASSIUM CHANNEL BLOCKING AGENT; PROSTACYCLIN; PROSTANOID; RIMONABANT; SULFONYLUREA; TETRABUTYLAMMONIUM; TETRYLAMMONIUM;

AGONIST; BLOOD VESSEL TONE; ENDOTHELIUM; HISTORY; HUMAN; HYPERPOLARIZATION; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE;

EID: 1542407602     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2003.11.015     Document Type: Article

References (49)

1. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 299:1980;373-376.
2. Furchgott R.F., Vanhoutte P.M. Endothelium-derived relaxing and contracting factors. FASEB J. 3:1989;2007-2017.
3. Lüscher TF, Vanhoutte PM. The endothelium: modulator of cardiovascular function. Boca Raton, FL: CRC Press, Inc.; 1990. p. 1-228.
4. Furchgott RF. Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that acid-activatable inhibitory factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In: Vanhoutte PM, editor. Vasodilatator: vascular smooth muscle, peptides, autonomic nerves and endothelium. New York: Raven Press; 1988. p. 401-14.
5. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 84:1987;9265-9269.
6. Ignarro LJ, Wood KS, Byrns RE. Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide radical. In: Vanhoutte PM, editor. Vasodilatation: vascular smooth muscle, peptides, autonomic nerves and endothelium. New York: Raven Press; 1988. p. 427-36.
7. Palmer R.M.J., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
8. Palmer R.M.J., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1988;664-666.
9. Palmer R.M.J., Moncada S. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem. Biophys. Res. Commun. 158:1989;348-352.
10. Rees D.D., Palmer R.M.J., Hodson H.F., Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br. J. Pharmacol. 96:1989;418-424.
11. Vanhoutte P.M. The end of a quest? Nature. 327:1987;459-460.
12. Vanhoutte P.M. The endothelium - modulator of vascular smooth-muscle tone. N. Engl. J. Med. 319:1988;512-513.
13. Vanhoutte P.M. State of the art lecture: endothelium and control of vascular function. Hypertension. 13:1989;658-667.
14. Vanhoutte P.M. Other endothelium-derived vasoactive factors. Circulation. 87:1993;V9-V17.
15. De Mey J.G., Claeys M., Vanhoutte P.M. Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery. J. Pharmacol. Exp. Ther. 222:1982;166-173.
16. Rubanyi G.M., Vanhoutte P.M. Nature of endothelium-derived relaxing factor: are there two different relaxing mediators? Circ. Res. 61:1987;II61-II67.
17. Hoeffner U., Boulanger C., Vanhoutte P.M. Proximal and distal dog coronary arteries respond differently to basal EDRF but not NO. Am. J. Physiol. 256:1989;H828-H831.
18. Hoeffner U., Félétou M., Flavahan N.A., Vanhoutte P.M. Canine arteries release two different endothelium-derived relaxing factors. Am. J. Physiol. 257:1989;H330-H333.
19. Boulanger C., Hendrickson H., Lorenz R.R., Vanhoutte P.M. Release of different relaxing factors by cultured porcine endothelial cells. Circ. Res. 64:1989;1070-1078.
20. Gauthier KM, Falck JR, Reddy LM, Campbell WB. 14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries. Pharmacol Res 2004.
21. Fleming I. Cytochrome P450 epoxygenases as EDHF synthase(s). Pharmacol Res 2004.
22. Vanhoutte PM. In: Vanhoutte PM, editor. Endothelium-derived hyperpolarizing factor. Harwood Academic Publishers; 1996. p. 1-338.
23. Kuriyama H., Suzuki H. The effects of acetylcholine on the membrane and contractile properties of smooth muscle cells of the rabbit superior mesenteric artery. Br. J. Pharmacol. 64:1978;493-501.
24. Bolton T.B., Lang R.J., Takewaki T. Mechanisms of action of noradrenaline and carbachol on smooth muscle of guinea-pig anterior mesenteric artery. J. Physiol. 351:1984;549-572.
25. Bolton T.B., Clapp L.H. Endothelial-dependent relaxant actions of carbachol and substance P in arterial smooth muscle. Br. J. Pharmacol. 87:1986;713-723.
26. Nakashima M., Mombouli J.V., Taylor A.A., Vanhoutte P.M. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J. Clin. Invest. 92:1993;2867-2871.
27. Vanhoutte PM. In: Vanhoutte PM, editor. Endothelium-derived hyperpolarizations. Harwood Academic Publishers; 1999. p. 1-436.
28. Vanhoutte PM. In: Vanhoutte PM, editor. EDHF 2000. London and New York: Taylor & Francis; 2001. p. 1-502.
29. Vanhoutte PM. In: Vanhoutte PM, editor. EDHF 2002. London and New York: Taylor & Francis; 2003. p. 1-427.
30. Félétou M., Vanhoutte P.M. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br. J. Pharmacol. 93:1988;515-524.
31. Cohen R.A., Vanhoutte P.M. Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation. 92:1995;3337-3349.
32. Komori K., Lorenz R.R., Vanhoutte P.M. Nitric oxide, ACh, and electrical and mechanical properties of canine arterial smooth muscle. Am. J. Physiol. 255:1988;H207-H212.
33. Busse R., Edwards G., Félétou M., Fleming I., Vanhoutte P.M. EDHF: bringing the concepts together. Trends Pharmacol. Sci. 23:2002;374-380.
34. Edwards G, Weston AH. Potassium and potassium clouds in endothelium-dependent hyperpolarizations. Pharmacol Res 2004.
35. Illiano S.C., Nagao T., Vanhoutte P.M. Calmidazolium, a calmodulin inhibitor, inhibits endothelium-dependent relaxations resistant to nitro-L-arginine in the canine coronary artery. Br. J. Pharmacol. 107:1992;387-392.
36. Nagao T., Illiano S.C., Vanhoutte P.M. Calmodulin antagonists inhibit endothelium-dependent hyperpolarization in the canine coronary artery. Br. J. Pharmacol. 107:1992;382-386.
37. Rubanyi G.M., Vanhoutte P.M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor(s). Am. J. Physiol. 250:1986;H822-H827.
38. Gryglewski R.J., Palmer R.M.J., Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 320:1986;454-456.
39. Kaw S., Hecker M. Endothelium-derived hyperpolarizing factor, but not nitric oxide or prostacyclin release is resistant to menadione-induced oxidative stress in the bovine coronary artery. Naunyn-Schmiedebergs Arch. Pharmacol. 359:1999;133-139.
40. Shimokawa H, Matoba T. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pharmacol Res 2004.
41. 2 is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knock-out mice. Proc. Natl. Acad. Sci. U.S.A. 97:2000;9747-9752.
42. Olmos L., Mombouli J.V., Illiano S., Vanhoutte P.M. cGMP mediates the desensitization to bradykinin in isolated canine coronary arteries. Am. J. Physiol. 268:1995;H865-H870.
43. Thollon C., Bidouard J.P., Cambarrat C., Delescluse I., Villeneuve N., Vanhoutte P.M.et al. Alteration of endothelium-dependent hyperpolarizations in porcine coronary arteries with regenerated endothelium. Circ. Res. 84:1999;371-377.
44. Thollon C., Fournet-Bourguignon M.P., Saboureau D., Lesage L., Reure H., Vanhoutte P.M.et al. Consequences of reduced production of NO on vascular reactivity of porcine coronary arteries after angioplasty: importance of EDHF. Br. J. Pharmacol. 136:2002;1153-1161.
45. Parkington HC, Coleman HA, Tare M. Prostacyclin and endothelium- dependent hyperpolarizations. Pharmacol Res 2004.
46. Nagao T., Illiano S., Vanhoutte P.M. Heterogeneous distribution of endothelium-dependent relaxations resistant to nitro-L-arginine in the arterial tree of the rat. Am. J. Physiol. 263:1992;1090-1094.
47. Boulanger C.M., Vanhoutte P.M. G-proteins and endothelium-dependent relaxations. J. Vascul. Res. 34:1997;175-185.
48. Vanhoutte P.M. Endothelium-derived free radicals: for worse and for better. J. Clin. Invest. 107:2001;23-25.
49. Corriu C., Félétou M., Canet E., Vanhoutte P.M. Endothelium derived factors and hyperpolarization of the carotid artery of the guinea-pig. Br. J. Pharmacol. 119:1996;959-964.